Publicaties

Totaal aantal publicaties: 5

Bayesian mixture models for phylogenetic source attribution from consensus sequences and time since infection estimates
Blenkinsop A, Sofocleous L, Di Lauro F, Kostaki EG, van Sighem A, Bezemer D, van de Laar T, Reiss P, de Bree G, Pantazis N, Ratmann O; on behalf of the HIV Transmission Eliminatinon Amsterdam (H-TEAM) Consortium
Statistical Methods in Medical Research. 2025 Feb; doi.org/10.1177/09622802241309750

Effectiveness of bi-monthly long-acting injectable cabotegravir and rilpivirine as maintenance treatment for HIV-1 in the Netherlands: results from the Dutch ATHENA national observational cohort
Jongen VW, Wit FWNM, Boyd A, van Eeden A, Brouwer AE, Soetekouw R, El Moussaoui R, Stalenhoef J, Sigaloff KCE, Mudrikova T, Gisolf J, Burger D, Wensing AMJ, van der Valk M; ATHENA National Observational HIV Cohort
The Lancet HIV. 2025 Jan; doi.org/10.1016/S2352-3018(24)00269-8

Hepatitis C Treatment and Behavioral Risk Among Men Who Have Sex With Men With HIV: Comparing Interferon and Direct-Acting Antiviral Eras
Hage K, Boyd A, van Santen DK, Brinkman K, Arends J, Lauw F, Rijnders B, van Eeden A, van der Valk M, Newsum A, Matser A, Schinkel J, Prins M
J Acquir Immune Defic Syndr. 2025  Jan; doi.org/10.1097/QAI.0000000000003550

Unsuccessful direct acting antiviral hepatitis C treatment among people with HIV: Findings from an international cohort
Harney BL, Sacks-Davis R, van Santen DK, Stewart AC, Matthews GV, Carson JM, Klein MB, Lacombe K, Wittkop L, Salmon D, Leleux O, Merchadou L, van der Valk M, Smit C, Prins M, Boyd A, Berenguer J, Jarrin I, Rauch A, Hellard ME, Doyle JS
Liver Int. 2025 Jan; doi.org/10.1111/liv.16203

Harmonisation of alcohol use data and mortality across a multi-national HIV cohort collaboration
Ingle SM, Trickey A, Lankina A, McGinnis KA, Justice A, Cavassini M, d' Arminio Monforte A, van Sighem A, Gill MJ, Crane HM, Obel N, Jarrin I, Wallner E, Guest J, Silverberg MJ, Vourli G, Wittkop L, Sterling TR, Satre DD, Burkholder GA, Costagliola D, Sterne JAC
Alcohol: Clinical and Experimental Research. 2025 Jan; doi.org/10.1111/acer.15522

Totaal aantal publicaties: 29

A Biomarker Profile Reflective of Preserved Thymic Function Is Associated With Reduced Comorbidities in Aging People With HIV: An AGEhIV Cohort Analysis
Vanbellinghen MC, Boyd A, Kootstra NA, Schim van der Loeff MF, van der Valk M, Reiss P; AGEhIV Cohort study group
the Journal of Infectious Diseases. 2024 Dec; doi.org/10.1093/infdis/jiae603

HIV prevention and missed opportunities among people with recently acquired HIV infection: Α protocol for a systematic review
Karakosta A, Ruiz-Burga E, Tariq S, Touloumi G, Nicholls EJ, Pantazis N, Jarrin I, Van der Valk M, Sabin C, Mussini C, Meyer L, Volny Anne A, Carlander C, Grabar S, Wittkop L, Spire B, Gill J, Porter K, Burns F, CASCADE Collaboration
PloS one. 2024 Dec; doi.org/10.1371/journal.pone.0295462

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, d’Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J; D:A:D cohort study; RESPOND cohort study
Clinical Infectious Diseases. 2024 Nov; doi.org/10.1093/cid/ciae228

HIV replication and tuberculosis risk among people living with HIV in Europe: A multicohort analysis, 1983-2015
Atkinson A, Kraus D, Banholzer N, Miro JM, Reiss P, Kirk O, Mussini C, Morlat P, Podlekareva D, Grant AD, Sabin C, van der Valk M, Le Moing V, Meyer L, Seng R, Castagna A, Obel N, Antoniadou A, Salmon D, Zwahlen M, Egger M, de Wit S, Furrer H, Fenner L; Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
PLoS One. 2024 Oct; doi.org/10.1371/journal.pone.0312035

Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study
Oomen PGA, Wit FWNM, Brinkman K, Vrouenraets SME, Mudrikova T, van Welzen BJ, van der Valk M; ATHENA National Observational Cohort Study
The Lancet HIV. 2024 Sept; doi.org/10.1016/S2352-3018(24)00150-4

Care interruptions and mortality among adults in Europe and North America
Trickey A, Zhang L, Rentsch CT, Pantazis N, Izquierdo R, Antinori A, Leierer G, Burkholder G, Cavassini M, Palacio-Vieira J, Gill MJ, Teira R, Stephan C, Obel N, Vehreschild JJ, Sterling TR, van der Valk M, Bonnet F, Crane HM, Silverberg MJ, Ingle SM, Sterne JAC; Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS. 2024 Aug; doi.org/10.1097/QAD.0000000000003924

Assessing the HIV care continuum among transgender women during 11 years of follow-up: results from the Netherlands’ ATHENA observational cohort
Jongen VW, Daans C, van Sighem A, Schim van der Loeff M, Hage K, Welling C, von Vaupel-Klein A, den Heijer M, Peters EJG, van der Valk M, Reiss P, Prins M, Hoornenborg E, the ATHENA observational HIV cohort
Journal of the International Aids Society. 2024 Aug; doi.org/10.1002/jia2.26317

Changes in bodyweight after initiating antiretroviral therapy close to HIV-1 seroconversion: an international cohort collaboration
Pantazis N, Sabin CA, Grabar S, van der Valk M, Jarrin I, van Sighem A, Meyer L, Carlander C, Gill J, Volny-Anne A, Spire B, Tariq S, Burns F, Costagliola D, Ruiz-Burga E, Touloumi G, Porter K, CASCADE Collaboration
The Lancet HIV. 2024 Aug; doi.org/10.1016/S2352-3018(24)00183-8

Similar Limited Protection Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Infection in Vaccinated Individuals With HIV and Comparable Controls
Verburgh ML, Boyd A, Schim van der Loeff MF, Bakker M, Wit FWNM, van der Valk M, Grobben M, van Pul L, Tejjani K, van Rijswijk J, van Gils MJ, Kootstra NA, van der Hoek L, Reiss P; AGEhIV Cohort Study
Open Forum Infectious Diseases. 2024 July; doi.org/10.1093/ofid/ofae380

Discrimination of the Veterans Aging Cohort Study Index 2.0 for predicting cause-specific mortality among persons with HIV in Europe and North America
Ambia J, Ingle SM, McGinnis K, Pantazis N, Silverberg MJ, Wittkop L, Kusejko K, Crane H, van Sighem A, Sarcletti M, Cozzi-Lepri A, Domingo P, Jarrin I, Wyen C, Hessamfar M, Zhang L, Cavassini M, Berenguer J, Sterling TR, Reiss P, Abgrall S, Gill MJ, Justice A, Sterne JAC, Trickey A
Open Forum Infectious Diseases. 2024 July; doi.org/10.1093/ofid/ofae333

Sources of Human Immunodeficiency Virus Infections Among Men Who Have Sex With Men With a Migration Background: A Viral Phylogenetic Case Study in Amsterdam, The Netherlands
Blenkinsop A, Pantazis N, Kostaki EG, Sofocleous L, van Sighem A, Bezemer D, van de Laar T, van der Valk M, Reiss P, de Bree G, Ratmann O, for the HIV Transmission Elimination Amsterdam (H-team) Consortium
the Journal of Infectious Diseases. 2024 July; doi.org/10.1093/infdis/jiae267

First-line antiretroviral therapy initiation for newly diagnosed people with HIV in the Netherlands: A retrospective analysis from 2016 to 2020
Oosterhof P, Wit FWNM, van Luien M, van der Valk M, Brinkman K, Burger DM
PLoS One. 2024 July; doi.org/10.1371/journal.pone.0307963

COVID-19 epidemiology and performance of the WHO clinical algorithm to diagnose COVID-19 in people with HIV from Ukraine
Vasylyev M, Buhiichyk V, Buhiichyck N, Groenendijk A, Ben I, Ostapiuk L, Sluzhynska M, Bierman WFW, van Kampen JJA, Wit FWNM, Reiss P, Rijnders BJA, Sluzhynska O, Rokx
International Journal of STD & AIDS. 2024 June; doi.org/10.1177/09564624241231016

De‐simplifying antiretroviral therapy from a single‐tablet to a two‐tablet regimen: Acceptance, patient‐reported outcomes, and cost savings in a multicentre study
Oosterhof P, De Zoete BGJA, Vanhommerig JW, Langebeek N, Gisolf EH, Van Hulzen AGW, Lammers AJJ, Weijsenfeld AM, Van der Valk M, Grintjes K, Van Crevel R, Van Luin M, Brinkman K, Burger DM
HIV Medicine. 2024 May 7; doi.org/10.1111/hiv.13655

Associations between change in BMI and the risk of hypertension and dyslipidaemia in people receiving integrase strand-transfer inhibitors, tenofovir alafenamide, or both compared with other contemporary antiretroviral regimens: a multicentre, prospective observational study from the RESPOND consortium cohorts
Byonanebye DM, Polizzotto MN, Maltez F, Rauch A, Grabmeier-Pfistershammer K, Wit F, De Wit S, Castagna A, d'Arminio Monforte A, Mussini C, Wasmuth JC, Fontas E, Abela I, Sarcletti M, Bansi-Matharu L, Jaschinski N, Peters L, Hosein SR, Vannappagari V, Cohen C, Bissio E, Mocroft A, Law M, Ryom L, Petoumenos K
The Lancet HIV. 2024 April 12; doi.org/10.1016/S2352-3018(23)00328-4 

Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration
Tusch E, Ryom L, Pelchen-Matthews A, Mocroft A, Elbirt D, Oprea C, Günthard HF, Staehelin C, Zangerle R, Suarez I, Vehreschild JJ, Wit F, Menozzi M, D'Arminio Monforte A, Spagnuolo V, Pradier C, Carlander C, Suanzes P, Wasmuth JC, Carr A, Petoumenos K, Borgans F, Bonnet F, De Wit S, El-Sadr W, Neesgaard B, Jaschinski N, Greenberg L, Hosein SR, Gallant J, Vannappagari V, Young L, Sabin C, Lundgren J, Peters L, Reekie J, D:A:D cohort study, RESPOND cohort study
Clinical Infectious Diseases. 2024 April 26; doi.org/10.1093/cid/ciae228

Targeted Screening for Viral Hepatitis Among Various Ethnic Groups in Amsterdam, the Netherlands
Van Dijk AM, Isfordink C, Boyd A, Galenkamp H, Schinkel J, Prins M, Takkenberg RB, Holleboom O, Van Der Valk M
Hepatitis Monthly. 2024 April 14; doi.org/10.5812/hepatmon-136838

Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies
Vos WAJW, Vadaq N, Matzaraki V, Otten T, Groenendijk AL, Blaauw MJT, van Eekeren LE, Brinkman K, de Mast Q, Riksen NP, Stalenhoef AFH, van Lunzen J, van der Ven AJAM, Blok WL, Stalenhoef JE
Viruses. 2024 April; doi.org/10.3390/v16040582

Recent abacavir use and incident cardiovascular disease in contemporary-treated people with HIV
Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, d'Arminio Monforte A, Vehreschild J, Sönnerborg A, Anne AV, Carr A, Bansi-Matharu L, Lundgren J, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Nescoi C, Van Der Valk M, Menozzi M, Muccini C, Mocroft A, Peters L, Ryom L; RESPOND Study Group.
AIDS. 2024 March; doi.org/10.1097/QAD.0000000000003373

Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study
Vasylyev M, Wit FWNM, Jordans CCE, Soetekouw R, Van Lelyveld SFL, Kootstra GJ, Delsing CE, Ammerlaan HSM, Van Kasteren MEE, Brouwer AE, Leyten EMS, Claassen MAA, Hassing RJ, Den Hollander JG, Van den Berge M, Roukens AHE, Bierman WFW, Groeneveld PHP, Lowe SH, Van Welzen BJ, Richel O, Nellen JF, Van den Berk GEL, Van der Valk M, Rijnders BJA, Rokx C
Open Forum Infectious Diseases; 2024 March 18; doi.org/10.1093/ofid/ofae160

Heavy antiretroviral exposure and exhausted/limited antiretroviral options: predictors and clinical outcomes
Mocroft A, Pelchen-Matthews A, Hoy J, Llibre JM, Neesgaard B, Jaschinski N, Domingo P, Rasmussen LD, Günthard HF, Surial B, Öllinger A, Knappik M, de Wit S, Wit F, Mussini C, Vehreschild J, Monforte AD, Sonnerborg A, Castagna A, Anne AV, Vannappagari V, Cohen C, Greaves W, Wasmuth JC, Spagnuolo V, Ryom L; for the RESPOND cohort collaboration.
AIDS. 2024 March 15; 10.1097/QAD.0000000000003798

Virological failure after switch to long-acting cabotegravir and rilpivirine injectable therapy: an in-depth analysis
Sacks-Davis R, van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration
The Lancet HIV. 2024 Feb; doi.org/10.1016/S2352-3018(23)00267-9

Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings
Van Geuns D, Arts RJW, De Vries G, Wit FWNM, Degtyareva SY, Brown J, Pareek M, Lipman M, Van Crevel R
AIDS. 2024 February 1; 10.1097/QAD.0000000000003747

Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe
Patmore LA, Van Eekhout KMA, Buti M, Koc ÖM, Agarwal K, De Knegt RJ, Janssen HLA, Van der Valk M, Lieveld FI, Hansen BE, Kramer M, De Bruijne J, Claassen MAA, Smit C, De Man RA, Takkenberg B †, Carey I †, Sonneveld MJ †, the HARP study group and HepNed
Journal of Hepatology. 2024 February; doi.org/10.1016/j.jhep.2023.10.019

All-cause mortality before and after DAA availability among people living with HIV and HCV: An international comparison between 2010 and 2019
Requena MB, Protopopescu C, Stewart AC, Van Santen DK, Klein MB, Jarrin I, Berenguer J, Wittkop L, Salmon D, Rauch A, Prins M, Van der Valk M, Sacks-Davis R, Hellard ME, Carrieri P, Lacombe K; InCHEHC Collaboration
International Journal of Drug Policy. 2024 February; doi.org/10.1016/j.drugpo.2023.104311

Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies
Sacks-Davis R, Van Santen DK, Boyd A, Young J, Stewart A, Doyle JS, Rauch A, Mugglin C, Klein M, Van der Valk M, Smit C, Jarrin I, Berenguer J, Lacombe K, Requena MB, Wittkop L, Leleux O, Bonnet F, Salmon D, Matthews GV, Guy R, Martin NK, Spelman T, Prins M, Stoove M, Hellard M; InCHEHC Collaboration
The Lancet HIV. 2024 Feb; doi.org/10.1016/S2352-3018(23)00267-9

Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study
van Dijk M, Boyd A, Brakenhoff SM, Isfordink CJ, van Zoest RA, Verhagen MD, de Knegt RJ, Drenth JPH, van der Valk M; HepNed study group
Liver Int. 2024 Jan; doi.org/10.1111/liv.15729

Recent data on the role of antiretroviral therapy in weight gain and obesity in persons living with HIV
Capeau J, Lagathu C, Béréziat, V
Current Opinion in HIV and AIDS. 2024 Jan; doi.org/10.1097/COH.0000000000000833

Sources of HIV infections among MSM with a migration background: a viral phylogenetic case study in Amsterdam, the Netherlands
Blenkinsop A, Pantazis N, Kostaki EG, Sofocleous L, van Sighem A, Bezemer D, van de Laar T, van der Valk M, Reiss P, de Bree G, Ratmann O
arXiv. 2024 Jan; doi.org/10.48550/arXiv.2401.08308

Totaal aantal publicaties: 30

Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral Treated People With Human Immunodeficiency Virus (HIV)
Chammartin F, Mocroft A, Egle A, Zangerle R, Smith C, Mussini C, Wit F, Vehreschild JJ, d'Arminio Monforte A, Castagna A, Bailly L, Bogner J, de Wit S, Matulionyte R, Law M, Svedhem V, Tallada J, Garges HP, Marongiu A, Borges ÁH, Jaschinski N, Neesgaard B, Ryom L, Bucher HC; RESPOND Study Group.
Clinical Infectious Diseases. 2023 Dec; doi.org/10.1093/cid/ciad671

The roles of the general practitioner and sexual health centre in HIV testing: comparative insights and impact on HIV incidence rates in the Rotterdam area, the Netherlands - a cross-sectional population-based study
Twisk DE, Meima A, Richardus JH, van Sighem A, Rokx C, den Hollander JG, Götz HM
BMC Public Health. 2023 Dec; doi.org/10.1186/s12889-023-17483-w

Prevalence of chronic HCV infection in EU/EEA countries in 2019 using multiparameter evidence synthesis
Thomadakis C, Gountas I, Duffell E, Gountas K, Bluemel B, Seyler T, Pericoli FM, Kászoni-Rückerl I, El-Khatib Z, Busch M, Schmutterer I,  Vanwolleghem T, Klamer S, Plettinckx E, Mortgat L, Van Beckhoven D,  Varleva T, Kosanovic Licina MJ, Nemeth Blazic T, Nonković D,  Theophanous F, Nemecek V, Maly M, Brehm Christensen P, Cowen S,  Rüütel K, Brummer-Korvenkontio H, Brouard C, Steffen G, Krings A, Dudareva S, Zimmermann R, Nikolopoulou G, Molnár Z, Kozma E, Gottfredsson M, Murphy N, Kondili LA, Tosti ME, Ciccaglione AR, Suligoi B, Nikiforova R, Putnina R, Jancoriene L, Seguin-Devaux C, Melillo T, Boyd A, van der Valk M, Op de Coul E, Whittaker R, Kløvstad H, Stępień M, Rosińska M, Valente C, Tato Marinho R, Popovici O, Avdičová M, Kerlik J, Klavs I, Maticic M, Diaz A, Del Amo J, Lundberg Ederth J, Axelsson M, Nikolopoulos G
The Lancet Regional Health Europe. 2023 Dec; doi.org/10.1016/j.lanepe.2023.100792

Impaired gut microbiota-mediated short-chain fatty acid production precedes morbidity and mortality in people with HIV
Sereti I, Verburgh ML, Gifford J, Lo A, Boyd A, Verheij E, Verhoeven A, Wit FWNM, Schim van der Loeff MF, Giera M, Kootstra NA, Reiss P, Vujkovic-Cvijin I
Cell Reports. 2023 Nov; doi.org/10.1016/j.celrep.2023.113336

HIV-1 drug resistance in people on dolutegravir-based antiretroviral therapy: a collaborative cohort analysis
Loosli T, Hossmann S, Ingle SM, Okhai H, Kusejko K, Mouton J, Bellecave P, van Sighem A, Stecher M, d'Arminio Monforte A, Gill MJ, Sabin CA, Maartens G, Günthard HF, Sterne JAC, Lessells R, Egger M, Kouyos RD
The Lancet HIV. 2023 Nov; doi.org/10.1016/s2352-3018(23)00228-x

Integrase strand-transfer inhibitor use and cardiovascular events in adults with HIV: an emulation of target trials in the HIV-CAUSAL Collaboration and the Antiretroviral Therapy Cohort Collaboration
Rein SM, Lodi S, Logan RW, Touloumi G, Antoniadou A, Wittkop L, Bonnet F, van Sighem A, van der Valk M, Reiss P, Klein MB, Young J, Jarrin I, d'Arminio Monforte A, Tavelli A, Meyer L, Tran L, Gill MJ, Lang R, Surial B, Haas AD, Justice AC, Rentsch CT, Phillips A, Sabin CA, Miro JM, Trickey A, Ingle SM, Sterne JAC, Hernán MA; Antiretroviral Therapy Cohort Collaboration and the HIV-CAUSAL Collaboration
The Lancet HIV. 2023 Nov; doi.org/10.1016/S2352-3018(23)00233-3

All-cause hospitalization among people living with HIV according to gender, mode of HIV acquisition, ethnicity and geographic origin in Europe and North America: Findings from the ART-CC cohort collaboration
Rein SM, Lampe FC, Ingle SM, Sterne JAC, Trickey A, Gill MJ, Papastamopoulos V, Wittkop L, van der Valk M, Kitchen M, Guest JL, Satre DD, Wandeler G, Galindo P, Castilho J, Crane HM, Smith CJ
Lancet Public Health. 2023 Oct; doi.org/10.1016/S2468-2667(23)00178-0

A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022
HIV Transmission Elimination AMsterdam (H-TEAM) Initiative
Euro Surveill. 2023 Oct; doi.org/10.2807/1560-7917.es.2023.28.40.2300515

Global variations in pubertal growth spurts in adolescents living with perinatal HIV
CIPHER global cohort collaboration
AIDS. 2023 Aug; doi.org/10.1097/QAD.0000000000003602

Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort Study
Álvarez H, Mocroft A, Ryom L, Neesgaard B, Edwards S, Svedhem V, Günthard HF, Zangerle R, Smith C, Castagna A, d'Arminio Monforte A, Wit F, Stecher M, Lehman C, Mussini C, Fontas E, González E, Wasmuth JC, Sönnerborg A, De Wit S, Chkhartishvili N, Stephan C, Petoumenos K, Jaschinski N, Vannappagari V, Gallant J, Young L, Volny Anne A, Greenberg L, Martín-Iguacel R, Poveda E, Llibre JM; RESPOND (International Cohort Consortium of Infectious Diseases) Study Group
Clinical Infectious Diseases. 2023 Aug; doi.org/10.1093/cid/ciad219

Gelderland naar 0 nieuwe hiv-infecties
Van der Starre C, van Jaarsveld E, Nijsten N, Pelgrim M, van Sighem A, van de Luijtgaarden M, Dielissen P, Richel O
Seksoa Magazine. 2023 Aug

Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation
Chalouni M, Trickey A, Ingle SM, Sepuvelda MA, Gonzalez J, Rauch A, Crane HM, Gill MJ, Rebeiro PF, Rockstroh JK, Franco RA, Touloumi G, Neau D, Laguno M, Rappold M, Smit C, Sterne JAC, Wittkop L; Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS. 2023 Aug; doi.org/10.1097/QAD.0000000000003594

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
Greenberg L, Ryom L, Bakowska E, Wit F, Bucher HC, Braun DL, Phillips A, Sabin C, d'Arminio Monforte A, Zangerle R, Smith C, De Wit S, Bonnet F, Pradier C, Mussini C, Muccini C, Vehreschild JJ, Hoy J, Svedhem V, Miró JM, Wasmuth JC, Reiss P, Llibre JM, Chkhartishvili N, Stephan C, Hatleberg CI, Neesgaard B, Peters L, Jaschinski N, Dedes N, Kuzovatova E, Van Der Valk M, Menozzi M, Lehmann C, Petoumenos K, Garges H, Rooney J, Young L, Lundgren JD, Bansi-Matharu L, Mocroft A, on behalf of the Respond and D:A:D study groups
Cancers. 2023 July; doi.org/10.3390/cancers15143640

No evidence of rapid reversibility of tenofovir alafenamide and/or integrase strand transfer inhibitor-associated weight gain
Verburgh ML, Wit FWNM, Boyd A, Reiss P, Van der Valk M
AIDS. 2023 July; doi.org/10.1097/QAD.0000000000003654

No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of SARS-CoV-2 infection in people with HIV in the Netherlands
Verburgh ML, van der Valk M, Rijnders BJA, Reiss P, Wit FWNM
AIDS. 2023 July; doi.org/10.1097/QAD.0000000000003577

Outcomes of bariatric surgery in people with HIV: a retrospective analysis from ATHENA cohort
Zino L, Wit F, Rokx C, den Hollander JG, van der Valk M, Richel O, Burger DM, Colbers A
Clinical Infectious Diseases. 2023 July; doi.org/10.1093/cid/ciad404

Robust Vaccine-Induced as Well as Hybrid B- and T-Cell Immunity across SARS-CoV-2 Vaccine Platforms in People with HIV
Verburgh ML, van Pul L, Grobben M, Boyd A, Wit FWNM, van Nuenen AC, van Dort KA, Tejjani K, van Rijswijk J, Bakker M, van der Hoek L, Schim van der Loeff MF, van der Valk M, van Gils MJ, Kootstra NA, Reiss P
Microbiol Spectr. 2023 June; doi.org/10.1128/spectrum.01155-23

Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptoms
Rakshasa-Loots AM, Bakewell N, Sharp DJ, Gisslén M, Zetterberg H, Alagaratnam J, Wit FWNM, Kootstra NA, Winston A, Reiss P, Sabin CA, Vera JH; COmorBidity in Relation to AIDS (COBRA) cohort
Translational Psychiatry. 2023 June; doi.org/10.1038/s41398-023-02489-0

Sexually transmitted infections in the Netherlands in 2022
Kayaert L, Sarink D, Visser M, van Wees DA, Willemstein IJM, Op de Coul ELM, Alexiou ZW, de Vries A, Kusters JMA, van Aar F, Götz HM, Vanhommerig JW, van Sighem AI, van Benthem BHB
RIVM. 2023 June

Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies
Trickey A, Ingle SM, Boyd A, Gill MJ, Grabar S, Jarrin I, Obel N, Touloumi G, Zangerle R, Rauch A, Rentsch CT, Satre DD, Silverberg MJ, Bonnet F, Guest J, Burkholder G, Crane H, Teira R, Berenguer J, Wyen C, Abgrall S, Hessamfar M, Reiss P, d'Arminio Monforte A, McGinnis KA, Sterne JAC, Wittkop L
J Viral Hepat. 2023 June; doi.org/10.1111/jvh.13863

Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
Trickey A, Sabin CA, Burkholder G, Crane H, d'Arminio Monforte A, Egger M, Gill MJ, Grabar S, Guest JL, Jarrin I, Lampe FC, Obel N, Reyes JM, Stephan C, Sterling TR, Teira R, Touloumi G, Wasmuth JC, Wit F, Wittkop L, Zangerle R, Silverberg MJ, Justice A, Sterne JAC
The Lancet HIV. 2023 May; doi.org/10.1016/s2352-3018(23)00028-0

COVID-19 in people with HIV in the Netherlands, the ATHENA cohort study
Wit FWNM, Reiss P, Rijnders B, Rokx C, Roukens A, Brinkman K, Van der Valk M
AIDS. 2023 May; doi.org/10.1097/QAD.0000000000003597

Adoption is not associated with immunological and virological outcomes in children with perinatally acquired HIV infection in the Netherlands
Van Den Hof M, Smit C, Fraaij PLA, Wolfs TFW, Geelen SPM, Scherpbier HJ, Schölvinck EH, Van Aerde K, Reiss P, Wit FWNM, Pajkrt D, on behalf of the ATHENA cohort study group
PLoS One. 2023 May; doi.org/10.1371/journal.pone.0284395

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study
Isfordink CJ, Boyd A, Sacks-Davis R, van Santen DK, Smit C, Martinello M, Stoove M, Berenguer J, Wittkop L, Klein MB, Rauch A, Salmon D, Lacombe K, Stewart A, Schinkel J, Doyle JS, Hellard M, van der Valk M, Matthews GV; InCHEHC study group
Lancet Public Health. 2023 Apr; doi.org/10.1016/S2468-2667(23)00056-7

Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGEhIV cohort study
Verheij E, Boyd A, Wit FW, Verboeket SO, Verburgh ML, van der Valk M, Schim van der Loeff MF, Reiss P
The Lancet HIV. 2023 March; doi.org/10.1016/S2352-3018(22)00400-3

HIV transmission among acutely infected participants of a Dutch cohort study 2015-2021 is not associated with large, clustered outbreaks
Prins HAB, Rokx C, Verbon A, van Sighem A, de Bree GJ, Dijkstra M, Prins JM, Reiss P, van Kampen JJA, van de Vijver DAMC
AIDS. 2023 Feb; doi.org/10.1097/QAD.0000000000003416

Characteristics and short- and long-term direct medical costs among adults with timely and delayed presentation for HIV care in the Netherlands
Popping S, Versteegh L, Nichols BE, Van de Vijver DAMC, Van Sighem AI, Reiss P, Geerlings S, Boucher CAB, Verbon A, on behalf of the ATHENA observational cohort
PLoS One. 2023 Feb; doi.org/10.1371/journal.pone.0280877

Hepatitis delta infection among persons living with HIV in Europe
Béguelin C, Atkinson A, Boyd A, Falconer K, Kirkby N, Suter-Riniker F, Günthard HF, Rockstroh JK, Mocroft A, Rauch A, Peters L, Wandeler G
Liver Int. 2023 Jan; doi.org/10.1111/liv.15519

External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection
Surial B, Ramírez Mena A, Roumet M, Limacher A, Smit C, Leleux O, Mocroft A, van der Valk M, Bonnet F, Peters L, Rockstroh JK, Günthard HF, Berzigotti A, Rauch A, Wandeler G, and the Swiss HIV Cohort Study, ATHENA Observational Cohort Study, EuroSIDA, ANRS CO3 Aquitaine Cohort
J HEP. 2023 Jan; doi.org/10.1016/j.jhep.2022.12.029

Effect of the introduction of screening for cancer precursor lesions on anal cancer incidence over time in people living with HIV: a nationwide cohort study
Van der Zee RP, Wit FWNM, Richel O, van der Valk M, Reiss P, de Vries HJC, Prins JM; ATHENA national observational HIV cohort
The Lancet HIV. 2023 Jan; doi.org/10.1016/S2352-3018(22)00368-X

Totaal aantal publicaties: 33

Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019
Van Santen DK, Sacks-Davis R, Stewart A, Boyd A, Young J, van der Valk M, Smit C, Rauch A, Braun DL, Jarrin I, Berenguer J, Lazarus JV, Lacombe K, Requena MB, Wittkop L, Leleux O, Salmon D, Bonnet F, Matthews G, Doyle JS, Spelman T, Klein MB, Prins M, Asselin J, Stoové MA, Hellard M; InCHEHC study group
EClinicalMedicine. 2022 Dec; doi.org/10.1016/j.eclinm.2022.101810

Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection
Lodi S, Klein M, Rauch A, Epstein R, Wittkop L, Logan R, Rentsch CT, Justice AC, Touloumi G, Berenguer J, Jarrin I, Egger M, Puoti M, D'Arminio Monforte A, Gill J, Salmon Ceron D, van Sighem A, Linas B, van der Valk M, Hernán MA; HepCAUSAL Collaboration
J Int AIDS Soc. 2022 Dec; doi.org/10.1002/jia2.26048

Clearance of Hepatitis B e Antigen in Untreated Chronic Hepatitis B Virus Infection: A Systematic Review and Meta-analysis
Mohareb AM, Liu AF, Kim AY, Coffie PA, Kouamé MG, Freedberg KA, Boyd A, Hyle EP
J Infect Dis. 2022 Nov; doi.org/10.1093/infdis/jiac168

Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
Weijsenfeld AM, Smit C, Wit FWNM, Mudrikova T, Nellen JFJB, van der Valk M, Pajkrt D; ATHENA National Observational HIV Cohort
Open Forum Infectious Diseases. 2022 Nov; doi.org/10.1093/ofid/ofac561

Change in Substance Use and the Effects of Social Distancing on Health-Related Quality of Life and Depressive Symptoms During the COVID-19 Pandemic in People Living With and Without HIV
Schaaf REA, Verburgh ML, Boyd A, Wit FW, Nieuwkerk PT, Schim van der Loeff MF, Reiss P; AGEhIV Study Group
J Acquir Immune Defic Syndr. 2022 Nov; doi.org/10.1097/QAI.0000000000003055

Eligibility criteria vs. need for pre-exposure prophylaxis: a reappraisal among men who have sex with men in Amsterdam, the Netherlands
De la Court F, Boyd A, Davidovich U, Hoornenborg E, Schim Van Der Loeff MF, De Vries HJC, Van Wees DA, Van Benthem BHB, Xiridou M, Matser A, Prins M
Epidemiol Infect. 2022 Nov; doi.org/10.1017/S0950268822001741

The impact of COVID-19-related restrictions in 2020 on sexual healthcare use, pre-exposure prophylaxis use, and sexually transmitted infection incidence among men who have sex with men in Amsterdam, the Netherlands
De la Court F, Boyd A, Coyer L, van den Elshout M, de Vries HJC, Matser A, Hoornenborg E, Prins M
HIV Med. 2022 Oct; doi.org/10.1111/hiv.13374

Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study
Isfordink C, Boyd A, Mocroft A, Kusejko K, Smit C, de Wit S, Mahungu T, Falconer K, Wandeler G, Cavassini M, Stöckle M, Schinkel J, Rauch A, Peters L, van der Valk M; for EuroSIDA, the Swiss HIV Cohort Study, and the ATHENA Observational Cohort
Open Forum Infectious Diseases. 2022 Oct; doi.org/10.1093/ofid/ofac508

The role of HIV/hepatitis B virus/hepatitis C virus RNA+triple infection in end-stage liver disease and all-cause mortality in Europe
Mocroft A, Geressu A, Beguelin C, Llibre JM, Lazarus JV, Tomazic J, Smidt J, Parczewski M, Brännström J, Sedlacek D, Degen O, van der Valk M, Paduta D, Flamholc L, Schmid P, Orkin C, Nielsen LN, Hoffmann C, Beniowski M, Oprea C, Begovac J, Peters L
AIDS. 2022 Oct; doi.org/10.1097/QAD.0000000000003406

Improving indicator-condition guided testing for HIV in the hospital setting (PROTEST 2·0): A multicenter, interrupted time-series analysi
Bogers SJ, Schim van der Loeff MF, Boyd A, Davidovich U, van der Valk M, Brinkman K, Sigaloff K, Branger J, Bokhizzou N, de Bree GJ, Reiss P, van Bergen JEAM, Geerlings SE; HIV Transmission Elimination AMsterdam (H-TEAM) Initiative
The Lancet Reg Health Eur. 2022 Oct; doi.org/10.1016/j.lanepe.2022.100515

Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection
Begré L, Béguelin C, Boyd A, Peters L, Rockstroh J, Günthard HF, Bernasconi E, Cavassini M, Lacombe K, Mocroft A, Wandeler G, Rauch A
Front Med. 2022 Sept; doi.org/10.3389/fmed.2022.988356

Risks and benefits of oral HIV pre-exposure prophylaxis for people with chronic hepatitis B
Mohareb AM, Larmarange J, Kim AY, Coffie PA, Kouamé MG, Boyd A, Freedberg KA, Hyle EP
The Lancet HIV. 2022 Aug; doi.org/10.1016/S2352-3018(22)00123-0

Recent Abacavir use and Incident Cardiovascular Disease in Contemporary Treated People Living with HIV
Jaschinski N, Greenberg L, Neesgaard B, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, De Wit S, Wit F, Pelchen-Matthews A, Mussini C, Castagna A, Pradier C, Monforte A, Vehreschild J, Sönnerborg A, Volny-Anne A, Carr A, Bansi-Matharu L, Lundgren J, Garges H, Rogatto F, Zangerle R, Günthard HF, Rasmussen LD, Nescoi C, Van Der Valk M, Menozzi M, Muccini C, Mocroft A, Peters L, Ryom L, RESPOND Study Group
AIDS. 2022 Aug; doi.org/10.1097/QAD.0000000000003373

Moving towards zero new HIV infections: The importance of combination prevention
Van Sighem A, van der Valk M
The Lancet Reg Health West Pac. 2022 Aug; doi.org/10.1016/j.lanwpc.2022.100558

Estimating the potential to prevent locally acquired HIV infections in a UNAIDS Fast-Track City, Amsterdam
Blenkinsop A, Monod M, van Sighem A, Pantazis N, Bezemer D, Op de Coul E, van de Laar T, Fraser C, Prins M, Reiss P, de Bree GJ, Ratmann O
Elife. 2022 Aug; doi.org/10.7554/eLife.76487

Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium
Neesgaard B, Greenberg L, Miró JM, Grabmeier-Pfistershammer K, Wandeler G, Smith C, et al
The Lancet HIV. 2022 July; doi.org/10.1016/S2352-3018(22)00094-7

The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study
Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van Bremen K, Beniowski M, Mikhalik J, Matthias Cavassini, Maltez F, Duvivier C, Uberti Foppa C, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L
HIV Med. 2022 July; doi.org/10.1111/hiv.13210

One in 10 Virally Suppressed Persons With HIV in The Netherlands Experiences ≥10% Weight Gain After Switching to Tenofovir Alafenamide and/or Integrase Strand Transfer Inhibitor
Verburgh ML, Wit FWNM, Boyd A, Verboeket SO, Reiss P, van der Valk M
Open Forum Infect Dis. 2022 June; doi.org/10.1093/ofid/ofac291

Sexually transmitted infections in the Netherlands in 2021
Van Wees DA, Visser M, van Aar F, Op de Coul ELM, Staritsky LE, Sarink D, Willemstein IJM, de Vries A, Kusters JMA, den Boogert E, Alexiou ZW, Götz HM, Jansen T, van Sighem AI, Heijne JCM
RIVM. 2022 June

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study
Trickey A, Zhang L, Gill MJ, MD, Bonnet F, Burkholder G, Castagna A, et al
The Lancet HIV. 2022 June; doi.org/10.1016/S2352-3018(22)00046-7

Similar Risk of Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Similar Nucleocapsid Antibody Levels in People With Well-Controlled Human Immunodeficiency Virus (HIV) and a Comparable Cohort of People Without HIV
Verburgh ML, Boyd A, Wit FWNM, Schim van der Loeff MF, van der Valk M, Bakker M, Kootstra NA, van der Hoek L, Reiss P
J Infect Dis. 2022 June; doi.org/10.1093/infdis/jiab616

Trends in Sexual Behavior and Sexually Transmitted Infections After Initiating Human Immunodeficiency Virus Pre-Exposure Prophylaxis in Men Who Have Sex with Men from Amsterdam, the Netherlands: A Longitudinal Exposure-Matched Study
Coyer L, Prins M, Davidovich U, van Bilsen WPH, Schim van der Loeff MF, Hoornenborg E, Matser A, Boyd A
AIDS Patient Care STDS. 2022 June; doi.org/10.1089/apc.2021.0219

Co-infection par les virus des hépatites B et D chez les personnes vivant avec le VIH
Boyd A, Melin P, Lacombe K
Hepato-Gastro & Oncologie Digestive. 2022 June; doi.org/10.1684/hpg.2022.2365

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium
Byonanebye DM, Polizzotto MN, Neesgaard B, Sarcletti M, Matulionyte R, Braun DL, Castagna A, de Wit S, Wit F, Fontas E, Vehreschild JJ, Vesterbacka J, Greenberg L, Hatleberg C, Garges H, Gallant J, Volny Anne A, Öllinger A, Mozer-Lisewska I, Surial B, Spagnuolo V, Necsoi C, van der Valk M, Mocroft A, Law M, Ryom L, Petoumenos K; RESPOND study group
HIV Med. 2022 March; doi.org/10.1111/hiv.13273

Growth and CD4 patterns of adolescents living with perinatally acquired HIV worldwide, a CIPHER cohort collaboration analysis
Jesson J, Crichton S, Quartagno M, Yotebieng M, Abrams EJ, Chokephaibulkit K, Le Coeur S, Aké-Assi MH, Patel K, Pinto J, Paul M, Vreeman R, Davies MA, Ben-Farhat J, Van Dyke R, Judd A, Mofenson L, Vicari M, Seage G 3rd, Bekker LG, Essajee S, Gibb D, Penazzato M, Collins IJ, Wools-Kaloustian K, Slogrove A, Powis K, Williams P, Matshaba M, Thahane L, Nyasulu P, Lukhele B, Mwita L, Kekitiinwa-Rukyalekere A, Wanless S, Goetghebuer T, Thorne C, Warszawski J, Galli L, van Rossum AMC, Giaquinto C, Marczynska M, Marques L, Prata F, Ene L, Okhonskaya L, Navarro M, Frick A, Naver L, Kahlert C, Volokha A, Chappell E, Pape JW, Rouzier V, Marcelin A, Succi R, Sohn AH, Kariminia A, Edmonds A, Lelo P, Lyamuya R, Ogalo EA, Odhiambo FA, Haas AD, Bolton C, Muhairwe J, Tweya H, Sylla M, D'Almeida M, Renner L, Abzug MJ, Oleske J, Purswani M, Teasdale C, Nuwagaba-Biribonwoha H, Goodall R, Leroy V
J Int AIDS Soc. 2022 March; doi.org/10.1002/jia2.25871

Testing and healthcare seeking behavior preceding HIV diagnosis among migrant and non-migrant individuals living in the Netherlands: Directions for early-case finding
Van Bilsen WPH, Bil JP, Prins JM, Brinkman K, Leyten E, van Sighem A, Bedert M, Davidovich U, Burns F, Prins M
PLoS One. 2022 March; doi.org/10.1371/journal.pone.0264435

Phylogenetic estimation of the viral fitness landscape of HIV-1 set-point viral load
Zhao L, Wymant C, Blanquart F, Golubchik T, Gall A, Bakker M, Bezemer D, Hall M, Ong SH, Albert J, Bannert N, Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, van Sighem A, van der Valk M, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C, Ferretti L
Virus Evol. 2022 March; doi.org/10.1093/ve/veac022

Increase in recreational drug use between 2008 and 2018: results from a prospective cohort study among HIV-negative men who have sex with men
Coyer L, Boyd A, Davidovich U, van Bilsen WPH, Prins M, Matser A
Addiction. 2022 March; doi.org/10.1111/add.15666

Children living with HIV in Europe: do migrants have worse treatment outcomes?
Chappell E, Kohns Vasconcelos M, Goodall RL, Galli L, Goetghebuer T, Noguera-Julian A, Rodrigues LC, Scherpbier H, Smit C, Bamford A, Crichton S, Navarro ML, Ramos JT, Warszawski J, Spolou V, Chiappini E, Venturini E, Prata F, Kahlert C, Marczynska M, Marques L, Naver L, Thorne C, Gibb DM, Giaquinto C, Judd A, Collins IJ; European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
HIV Med. 2022 Feb; doi.org/10.1111/hiv.13177

A highly virulent variant of HIV-1 circulating in the Netherlands
Wymant C, Bezemer D, Blanquart F, Ferretti L, Gall A, Hall M, Golubchik T, Bakker M, Ong SH, Zhao L, Bonsall D, de Cesare M, MacIntyre-Cockett G, Abeler-Dörner L, Albert J, Bannert N,  Fellay J, Grabowski MK, Gunsenheimer-Bartmeyer B, Günthard HF, Kivelä P, Kouyos RD, Laeyendecker O, Meyer L, Porter K, Ristola M, van Sighem A, Berkhout B, Kellam P, Cornelissen M, Reiss P, Fraser C, Netherlands ATHENA HIV Observational Cohort; BEEHIVE Collaboration
Science. 2022 Feb; doi.org/10.1126/science.abk1688

Integrase Strand Transfer Inhibitor Use and Cancer Incidence in a Large Cohort Setting
Greenberg L, Ryom L, Neesgaard B, Miró JM, Dahlerup Rasmussen L, Zangerle R, Grabmeier-Pfistershammer K, Günthard HF, Kusejko K, Smith C, Mussini C, Menozzi M, Wit F, Van Der Valk M, d'Arminio Monforte A, De Wit S, Necsoi C, Pelchen-Matthews A, Lundgren J, Peters L, Castagna A, Muccini C, Vehreschild JJ, Pradier C, Bruguera Riera A, Sönnerborg A, Petoumenos K, Garges H, Rogatto F, Dedes N, Bansi-Matharu L, Mocroft A; RESPOND Study Group
Open Forum Infect Dis. 2022; doi.org/10.1093/ofid/ofac029

Low HCV-viremia prevalence yet continued barriers to direct-acting antiviral treatment in people living with HIV in the Netherlands
Isfordink CJ, Smit C, Boyd A, de Regt MJA, Rijnders BJA, van Crevel R, Ackens RP, Reiss P, Arends JE, van der Valk M, ATHENA observational cohort
AIDS. 2022 Jan; doi.org/10.1097/QAD.0000000000003159

Many but small HIV-1 non-B transmission chains in the Netherlands
Bezemer D, Blenkinsop A, Hall M, van Sighem A, Cornelissen M, Wessels E, van Kampen J, van de Laar T, Reiss P, Fraser C, Ratmann O
AIDS. 2022 Jan; 10.1097/QAD.0000000000003074

Totaal aantal publicaties: 24

Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants
Verheij E, Wit FW, Verboeket SO, Schim van der Loeff MF, Nellen JF, Reiss P, Kirk GD
J Acquir Immune Defic Syndr. 2021 Jan; doi.org/10.1097/QAI.0000000000002532

Monitoring recently acquired HIV infections in Amsterdam, the Netherlands: the attribution of test locations
Slurink I, Van de Baan F, Van Sighem A, Van Dam AP, Van de Laar T, de Bree G, Van Benthem B, Op de Coul E
Frontiers in Reproductive Health, section HIV and STIs. 2021 Feb; doi.org/10.3389/frph.2021.568611

HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study
Smit C, Boyd A, Rijnders BJA, van de Laar TJW, Leyten EM, Bierman WF, Brinkman K, Claassen MAA, den Hollander J, Boerekamps A, Newsum AM, Schinkel J, Prins M, Arends JE, Op de Coul ELM, van der Valk M, Reiss P; ATHENA observational cohort
The Lancet HIV. 2021 Feb; doi.org/10.1016/S2352-3018(20)30301-5

Cost-effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
Boettiger DC, Newall AT, Philips A, Bendavid E, Law MG, Ryom L, Reiss P, Mocroft A, Bonnet F, Weber R, El-Sadr W, d'Arminio Monforte A, de Wit S, Pradier C, Hatleberg CI, Lundgren J, Sabin C, Kahn JG, Kazi DS
The Journal of the International AIDS Society. 2021 Mar; doi.org/10.1002/jia2.25690

Risk for Non–AIDS-Defining and AIDS-Defining Cancer of Early Versus Delayed Initiation of Antiretroviral Therapy: A Multinational Prospective Cohort Study
Chammartin F, Lodi S, Logan R, Ryom L, Mocroft A, Kirk O, d'Arminio Monforte A, Reiss P, Phillips A, El-Sadr W, Hatleberg CI, Pradier C, Bonnet F, Law M, De Wit S, Sabin C, Lundgren JD, Bucher HC
Annals of Internal Medicine. 2021 Mar; doi.org/10.7326/M20-5226

Understanding Reasons for HIV Late Diagnosis: A Qualitative Study Among HIV‑Positive Individuals in Amsterdam, The Netherland
Bedert M, Davidovich U, de Bree G, van Bilsen W, van Sighem A, Zuilhof W, Brinkman K, van der Valk M, de Wit J
AIDS and Behavior. 2021 Mar; doi.org/10.1007/s10461-021-03239-3

Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study
Petoumenos K, Kuwanda L, Ryom L, Mocroft A, Reiss P, De Wit S, Pradier C, Phillips A, Hatleberg CI, d'Arminio Monforte A, Weber R, Sabin CA, Lundgren J, Law MG, D:A:D Study group
J Acquir Immune Defic Syndr. 2021 Apr; doi.org/10.1097/QAI.0000000000002603

Changes in lung function among treated HIV-positive and HIV-negative individuals: analysis of the prospective AGEhIV cohort study
Verboeket SO, Body A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, van Steenwijk RP, Drummond MB, Kirk GD, Reiss P, on behalf of the AGEhIV Cohort Study
The Lancet Healthy Longevity. 2021 Apr; doi.org/10.1016/S2666-7568(21)00033-7

Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents
The RESPOND Study Group
AIDS. 2021 May; doi.org/10.1097/QAD.0000000000002811

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participant
Verboeket SO, Boyd A, Wit FW, Verheij E, Schim van der Loeff MF, Kootstra N, van der Valk M, Reiss P, AGEhIV Cohort Study Group
PLoS One. 2021 May; doi.org/10.1371/journal.pone.0251205

2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of HIV treatment response from incomplete baseline information in different healthcare settings
Revell AD, Dechao W, Perez Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem A, Rehm CA, Agan B, Alvarez-Uria G, Montaner JSG, Lane HC, Larder BA; RDI study group
Journal of Antimicrobial Chemotherapy. 2021 Jun; doi.org/10.1093/jac/dkab078

No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL
Atkinson A, Miro JM, Mocroft A, Reiss P, Kirk O, Morlat P, Ghosn J, Stephan C, Mussini C, Antoniadou A, Doerholt K, Girardi E, De Wit S, Kraus D, Zwahlen M, Furrer H, the Opportunistic Infections Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD
J Int AIDS Soc. 2021 Jun; doi.org/10.1002/jia2.25726

Sexually transmitted infections in the Netherlands in 2020
Staritsky LE, Visser M, van Aar F, Op de Coul ELM, Heijne JCM, van Wees DA, Kusters JMA, Alexiou ZW, de Vries A, Götz HM, Nielen MMJ, van Sighem AI, van Benthem BHB
RIVM. 2021 Jun

Normal structural brain development in adolescents treated for perinatally acquired HIV: a longitudinal imaging study
Van den Hof M, Jellema PEJ, Ter Haar AM, Scherpbier HJ, Schrantee A, Kaiser A, Caan MWA, Majoie CBLM, Reiss P, Wit FWNM, Mutsaerts HMM, Pajkrt D
AIDS. 2021 Jul; doi.org/10.1097/QAD.0000000000002873

Consensus statement on the role of health systems in advancing the long-term well-being of people living with HIV
Lazarus JV, Safreed-Harmon K, Kamarulzaman A, Anderson J, Baptista Leite R, Behrens G, Gail Bekker L, Bhagani S, Brown D, Brown G, Buchbinder S, Caceres C, Cahn PE, Carrieri P, Caswell G, Cooke GS, d'Arminio Monforte A, Dedes N, Del Amo J, Elliott R, El-Sadr WM, Fuster-Ruiz de Apodaca MJ, Guaraldi G, Hallett T, Harding R, Hellard M, Jaffar S, Kall M, Klein M, Lewin SR, Mayer K, Pérez-Molina JA, Moraa D, Naniche D, Nash D, Noori T, Pozniak A, Rajasuriar R, Reiss P, Rizk N, Rockstroh J, Romero D, Sabin C, Serwadda D, Waters L
Nature Communications. 2021 Jul; doi.org/10.1038/s41467-021-24673-w

Offering a choice of daily and event-driven preexposure prophylaxis for men who have sex with men in the Netherlands: a cost-effectiveness analysis
Van Hoek AJ, Reitsema M, Xiridou M, van Sighem A, van Benthem B, Wallinga J, van Duijnhoven Y, Schim van der Loeff M, Prins M, Hoornenborg E, Amsterdam PrEP Project Team in the HIV Transmission Elimination Amsterdam (H-TEAM) Initiative
AIDS. 2021 Aug; doi.org/10.1097/QAD.0000000000002913

Incidence of HCV Reinfection Among HIV-Positive MSM and Its Association With Sexual Risk Behavior: A Longitudinal Analysis
Newsum AM, Matser A, Schinkel J, van der Valk M, Brinkman K, van Eeden A, Lauw FN, Rijnders BJA, van de Laar TJW, van de Kerkhof M, Smit C, Boyd A, Arends JE, Prins M, MSM Observational Study of Acute Infection with hepatitis C (MOSAIC) study group
Clin Infect Dis. 2021 Aug; doi.org/10.1093/cid/ciaa645

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels compared to protease inhibitor-based therapy
Pasternak AO, Vroom J, Kootstra NA, Wit FW, de Bruin M, De Francesco D, Bakker M, Sabin CA, Winston A, Prins JM, Reiss P, Berkhout B; Co-morBidity in Relation to Aids (COBRA) Collaboration
Elife. 2021 Sep; doi.org/10.7554/eLife.68174

Quality of life among people living with HIV in England and the Netherlands: a population-based study
Popping S, Kall M, Nichols BE, Stempher E, Versteegh L, van de Vijver DAMC, van Sighem A, Versteegh M, Boucher C, Delpech V, Verbon A
The Lancet Reg Health Europe. 2021 Sep; doi.org/10.1016/j.lanepe.2021.100177

The complement pathway is activated in people with HIV and is associated with non-AIDS comorbidities
Vujkovic-Cvijin I, Sortino O, Verheij E, Wit FW, Kootstra NA, Sellers B, Schim van der Loeff M, Belkaid Y, Reiss P, Sereti I
J Infect Dis. 2021 Oct; doi.org/10.1093/infdis/jiab096

Discriminating Between Premigration and Postmigration HIV Acquisition Using Surveillance Data
Pantazis N, Rosinska M, van Sighem A, Quinten C, Noori T, Burns F, Cortes Martins H, Kirwan PD, O'Donnell K, Paraskevis D, Sommen C, Zenner D, Pharris A
J Acquir Immune Defic Syndr. 2021 Oct; doi.org/10.1097/QAI.0000000000002745

Children living with HIV in Europe: do migrants have worse treatment outcomes?
Chappell E, Kohns Vasconcelos M, Goodall RL, Galli L, Goetghebuer T, Noguera-Julian A, Rodrigues LC, Scherpbier H, Smit C, Bamford A, Crichton S, Navarro ML, Ramos JT, Warszawski J, Spolou V, Chiappini E, Venturini E, Prata F, Kahlert C, Marczynska M, Marques L, Naver L, Thorne C, Gibb DM, Giaquinto C, Judd A, Collins IJ; European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)
HIV Med. 2021 Oct; doi.org/10.1111/hiv.13177

Malignancies among children and young people with HIV in Western and Eastern Europe and Thailand
The European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC) study group
AIDS. 2021 Oct; doi.org/10.1097/QAD.0000000000002965

Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium
Bansi-Matharu L, Phillips A, Oprea C, Grabmeier-Pfistershammer K, Günthard HF, De Wit S, Guaraldi G, Vehreschild JJ, Wit F, Law M, Wasmuth JC, Chkhartishvili N, d'Arminio Monforte A, Fontas E, Vesterbacka J, Miro JM, Castagna A, Stephan C, Llibre JM, Neesgaard B, Greenberg L, Smith C, Kirk O, Duvivier C, Dragovic G, Lundgren J, Dedes N, Knudsen A, Gallant J, Vannappagari V, Peters L, Elbirt D, Sarcletti M, Braun DL, Necsoi C, Mussini C, Muccini C, Bolokadze N, Hoy J, Mocroft A, Ryom L
The Lancet HIV. 2021 Nov; doi.org/10.1016/S2352-3018(21)00163-6

Totaal aantal publicaties: 27

Frailty is associated with mortality and incident comorbidity among middle-aged HIV-positive and HIV-negative participants
Verheij E, Kirk GD, Wit FW, van Zoest RA, Verboeket SO, Lemkes BA, Schim van der Loeff MF, Reiss P
J Infect Dis. 2020 Jan; doi.org/10.1093/infdis/jiaa010

Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies
Trickey A, May MT, Gill MJ, Grabar S, Vehreschild J, Wit FWNM, Bonnet F, Cavassini M, Abgrall S, Berenguer J, Wyen C, Reiss P, Grabmeier-Pfistershammer K, Guest JL, Shepherd L, Teira R, d'Arminio Monforte A, Del Amo J, Justice A, Costagliola D, Sterne JAC
Int J Cancer. 2020 Jan; doi.org/10.1002/ijc.32895

HIV-negative Men Who Have Sex with Men have higher CD8+ T-cell Counts and Lower CD4+/CD8+ T-cell Ratios compared to HIV-negative Heterosexual Men
Verboeket SO, Wit FW, Verheij E, van Zoest RA, Kootstra NA, van der Valk M, Prins JM, Schim van der Loeff MF, Reiss P
J Infect Dis. 2020 Jan; doi.org/10.1093/infdis/jiaa048

Peritransition Outcomes of Southeast Asian Adolescents and Young Adults With HIV Transferring From Pediatric to Adult Care
Sohn AH, Chokephaibulkit K, Lumbiganon P, Hansudewechakul R, Gani YM, Van Nguyen L, Mohamed TJ, Teeraananchai S, Sethaputra C, Singtoroj T, Ananworanich J, Reiss P, Kerr SJ
J Adolesc Health. 2020 Jan; doi.org/10.1016/j.jadohealth.2019.07.02

Acute hepatitis C infection among adults with HIV in the Netherlands between 2003 and 2016: a capture-recapture analysis for the 2013 to 2016 period
Boender TS, Op de Coul E, Arends J, Prins M, van der Valk M, van der Meer JTM, van Benthem B, Reiss P, Smit C
Euro Surveill. 2020 Feb; doi.org/10.2807/1560-7917.ES.2020.25.7.1900450

Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART
Pasternak AO, Grijsen ML, Wit FW, Bakker M, Jurriaans S, Prins JM, Berkhout B
JCI Insight. 2020 Mar; doi.org/10.1172/jci.insight.134196

Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
Dickinson L, Gurjar R, Stöhr W, Bonora S, Owen A, D'Avolio A, Cursley A, Molina JM, Fäetkenheuer G, Vandekerckhove L, Di Perri G, Pozniak A, Richert L, Raffi F, Boffito M; NEAT001/ANRS143 Study Group
J Antimicrob Chemother. 2020 Mar; doi.org/10.1093/jac/dkz479

Outcomes of second‐line antiretroviral therapy among children living with HIV: a global cohort analysis
The Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration
J Int AIDS Soc. 2020 Apr; doi.org/10.1002/jia2.25477

Decreased time to viral suppression after implementation of targeted testing and immediate initiation of treatment of acute HIV infection among men who have sex with men in Amsterdam
Dijkstra M, van Rooijen MS, Hillebregt MM, van Sighem A, Smit C, Hogewoning A, Davidovich U, Heijman T, Hoornenborg E, Reiss P, van der Valk M, Prins M, Prins JM, Schim van der Loeff MF, de Bree GJ
Clin Infect Dis. 2020 May; doi.org/10.1093/cid/ciaa505

Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study
Rokx C, Borjas Howard JF, Smit C, Wit FW, Pieterman ED, Reiss P, Cannegieter SC, Lijfering WM, Meijer K, Bierman W, Tichelaar V, Rijnders BJA, on behalf of the ATHENA observational HIV cohort
PLoS Med. 2020 May; doi.org/10.1371/journal.pmed.1003101

HIV-associated gut dysbiosis is independent of sexual practice and correlates with noncommunicable diseases
Vujkovic-Cvijin I, Sortino O, Verheij E, Sklar J, Wit FW, Kootstra NA, Sellers B, Brenchley JM, Ananworanich J, Loeff MSV, Belkaid Y, Reiss P, Sereti I
Nat Commun. 2020 May; doi.org/10.1038/s41467-020-16222-8

Withholding primary PcP prophylaxis in virologically suppressed HIV patients: An emulation of a pragmatic trial in COHERE
Atkinson A, Zwahlen M, Barger D, d'Arminio Monforte A, De Wit S, Ghosn J, Girardi E, Svedhem-Johansson V, Morlat P, Mussini C, Noguera-Julian A, Stephan C, Touloumi G, Kirk O, Mocroft A,Reiss P, Miro JM, Carpenter JR, Furrer H; Opportunistic Infections Project Working Group of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Clin Infect Dis. 2020 May; doi.org/10.1093/cid/ciaa615

Monitoring progress towards the first UNAIDS 90-90-90 target in key populations living with HIV in Norway
Whittaker R, Case KK, Nilsen Ø, Blystad H, Cowan S, Kløvstad H, van Sighem A
BMC Infectious Diseases. 2020 Jun; doi.org/10.1186/s12879-020-05178-1

Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy
Van Welzen BJ, Smit C, Boyd A, Lieveld FI, Mudrikova T, Reiss P, Brouwer AE, Hoepelman AIM, Arends JE
Open Forum Infect Dis. 2020 Jun; doi.org/10.1093/ofid/ofaa226

Sexually transmitted infections in the Netherlands in 2019
Staritsky LE, Visser M, van Aar F, Op de Coul ELM, Heijne JCM, Götz HM, Nielen MMJ, Sighem AI, van Benthem BHB
RIVM. 2020 June

Technical and Psychosocial Challenges of mHealth Usage for Antiretroviral Therapy Adherence Among People Living With HIV in a Resource-Limited Setting: Case Series
Ngowi KM, Lyamuya F, Mmbaga BT, Muro E, Hillu Z, Shirima M, Aarnoutse RE, Ag Sprangers M, Nieuwkerk PT, Reiss P, Sumari-de Boer M
JMIR Form Res. 2020 Jun; doi.org/ 10.2196/14649

The impact of immunosuppression on chronic kidney disease in people living with HIV; the D:A:D study
Ryom L, Lundgren JD, Reiss P, Ross M, Kirk O, Fux CA, Morlat P, Fontas E, Smith C, De Wit S, d'Arminio Monforte A, El Sadr W, Hatleberg C, Phillips A, Sabin C, Law M, Mocroft A; D:A:D Study Group
J Infect Dis. 2020 Jul; doi.org/10.1093/infdis/jiaa396

How to RESPOND to Modern Challenges for People Living with HIV: A Profile for a New Cohort Consortium
The Respond Study Group
Microorganisms. 2020 Jul; doi.org/10.3390/microorganisms8081164

CD4/CD8 ratio and the risk of Kaposi sarcoma or non-Hodgkin lymphoma in the context of efficiently treated HIV infection: a collaborative analysis of 20 European cohort studies
Caby F, Guiguet M, Weiss L, Winston A, Miro JM, Konopnicki D, Le Moing V, Bonnet F, Reiss P, Mussini C, Poizot-Martin I, Taylor N, Skoutelis A, Meyer L, Goujard C, Bartmeyer B, Boesecke C, Antinori A, Quiros-Roldan E, Wittkop L, Frederiksen C, Castagna A, Thurnheer MC, Svedhem V, Jose S, Costagliola D, Mary-Krause M, Grabar S; for the (CD4/CD8 ratio and cancer risk) project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord
Clinical Infectious Diseases. 2020 Aug; doi.org/10.1093/cid/ciaa1137

Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?
Vourli G, Noori T, Pharris A, Porter K, Axelsson M, Begovac J, Cazein F, Costagliola D, Cowan S, Croxford S, d'Arminio Monforte A, Delpech V, Díaz A, Girardi E, Gunsenheimer-Bartmeyer B, Hernando V, Leierer G, Lot F, Nunez O, Obel N, Op de Coul E, Paraskeva D, Patrinos S, Reiss P, Schmid D, Sonnerborg A, Suligoi B, Supervie V, van Sighem A, Zangerle R, Touloumi G; European HIV Continuum of Care Working Group
Clinical Infectious Diseases. 2020 Sep; doi.org/10.1093/cid/ciaa696

Returning of antiretroviral medication dispensed over a period of 8 months suggests non-adherence despite full adherence according to real time medication monitoring
Ngowi KM, Masika L, Lyamuya F, Muro E, Mmbaga BT, Sprangers MAG, Nieuwkerk PT, Aarnoutse RE, Reiss P, Sumari-de Boer IM
AIDS Res Ther. 2020 Sep; doi.org/10.1186/s12981-020-00313-z

Monocyte and T cell immune phenotypic profiles associated with age advancement differ between people with HIV, lifestyle-comparable controls and blood donors
De Francesco D, Sabin C, Reiss P, Kootstra N, on behalf of The Co-morBidity in Relation to Aids (COBRA) Collaboration
Front. Immunol. 2020 Oct; doi.org/10.3389/fimmu.2020.581616

Differences in location of cerebral white matter hyperintensities in children and adults living with a treated HIV infection: A retrospective cohort comparison
Van Genderen JG, Van den Hof M, Boyd AC, Caan MWA, Wit FWNM, Reiss P, Pajkrt D
PLoS One. 2020 Oct; doi.org/10.1371/journal.pone.0241438

Estimating the burden of HIV late presentation and its attributable morbidity and mortality across Europe 2010–2016
The Late Presentation Working Groups in EuroSIDA and COHERE
BMC Infect Dis. 2020 Oct; doi.org/10.1186/s12879-020-05261-7

Rationale, design and initial results of an educational intervention to improve provider-initiated HIV testing in primary care
Bogers S, Schim van der Loeff M, van Dijk N, Groen K, Groot Bruinderink M, de Bree G, Reiss P, Geerlings S, van Bergen J
Family Practice. 2020 Dec; doi.org/10.1093/fampra/cmaa139

Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium
Neesgaard B, Mocroft A, Zangerle R, Wit F, Lampe F, Günthard HF, Necsoi C, Law M, Mussini C, Castagna A, d'Arminio Monforte A, Pradier C, Chkhartisvilli N, Reyes-Uruena J, Vehreschild JJ, Wasmuth JC, Sönnerborg A, Stephan C, Greenberg L, Llibre JM, Volny-Anne A, Peters L, Pelchen-Matthews A, Vannappagari V, Gallant J, Rieger A, Youle M, Braun D, De Wit S, Petoumenos K, Borghi V, Spagnuolo V, Tsertsvadze T, Lundgren J, Ryom L, RESPOND study group
PLoS One. 2020 Dec; doi.org/10.1371/journal.pone.0243625

Plasma inflammatory biomarkers predict CD4+ T-cell recovery and viral rebound in HIV-1 infected Africans on suppressive antiretroviral therapy
Kroeze S, Rossouw TM, Steel HC, Wit FW, Kityo CM, Siwale M, Akanmu S, Mandaliya K, De Jager M, Ondoa P, Reiss P, Rinke De Wit TF, Kootstra NA, Hamers RL
J Infect Dis. 2020 Dec; doi.org/10.1093/infdis/jiaa787